These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12036934)

  • 1. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
    Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
    Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma.
    Sauter ER; Takemoto R; Litwin S; Herlyn M
    Cancer Gene Ther; 2002 Oct; 9(10):807-12. PubMed ID: 12224020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.
    Bastian BC; Kashani-Sabet M; Hamm H; Godfrey T; Moore DH; Bröcker EB; LeBoit PE; Pinkel D
    Cancer Res; 2000 Apr; 60(7):1968-73. PubMed ID: 10766187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
    Yamaura M; Takata M; Miyazaki A; Saida T
    Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model.
    Sauter ER; Herlyn M; Liu SC; Litwin S; Ridge JA
    Clin Cancer Res; 2000 Feb; 6(2):654-60. PubMed ID: 10690551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
    Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
    Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
    Utikal J; Udart M; Leiter U; Peter RU; Krähn G
    Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
    Nai G; Marques M
    Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
    Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
    Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation.
    Treszl A; Adány R; Rákosy Z; Kardos L; Bégány A; Gilde K; Balázs M
    Cytometry B Clin Cytom; 2004 Jul; 60(1):37-46. PubMed ID: 15221868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant melanoma with monster cells showing massive cyclin D1 amplification.
    Pouryazdanparast P; Newman M; Mafee M; Guitart J; Gerami P
    Am J Dermatopathol; 2009 Jun; 31(4):402-3. PubMed ID: 19461251
    [No Abstract]   [Full Text] [Related]  

  • 12. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation.
    Burnworth B; Popp S; Stark HJ; Steinkraus V; Bröcker EB; Hartschuh W; Birek C; Boukamp P
    Oncogene; 2006 Jul; 25(32):4399-412. PubMed ID: 16547504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
    Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
    Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer.
    Utikal J; Udart M; Leiter U; Kaskel P; Peter RU; Krähn G
    Cancer Lett; 2005 Mar; 219(2):197-204. PubMed ID: 15723720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
    Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
    Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
    de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
    Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.